Mukka Proteins Limited (MUKKA) — Financial Results | 13 August 2026(2 announcements)

Mukka Proteins Limited announced its Q1 FY27 investor presentation, highlighting strong performance and strategic progress. Revenue reached ₹1,403.60 crores with EBITDA of [amount context mismatch] crores and PAT of ₹57.10 crores, reflecting robust growth. The company advanced sustainability initiatives, including MarinTrust certification and waste-to-value projects, while expanding capacity through acquisitions like Delta Marine Products for ₹11.1 crore. Oman facility development and leachate treatment contracts underscore its circular economy focus. Export revenue constituted 89.5% of total, driven by global demand for fishmeal, fish oil, and insect protein. The presentation emphasized long-term growth targets exceeding ₹3,000 crores by FY30, supported by policy tailwinds and structural shifts in aquaculture feed. Key risks include fishmeal supply constraints and regulatory challenges, though recent customs litigation resolution removed a ₹15.2 crore liability. The company maintains leadership in fish protein exports with ~25–30% market share and is positioning insect biotech as a high-growth ESG-aligned segment.

Mukka Proteins reported consolidated revenue of ₹4896.5 Mn in Q1 FY27, up 186.7% YoY, with PAT at ₹186.3 Mn, up 1072.5% YoY, driven by strong domestic and export demand, improved realizations, and favorable market conditions amid global fish meal supply constraints.